ChemicalBook > Product Catalog >Biochemical Engineering >Amino Acids and Derivatives >Cysteine derivatives >DL-Homocysteine
DL-Homocysteine
- CAS No.
- 454-29-5
- Chemical Name:
- DL-Homocysteine
- Synonyms
- DL-Homocysteine,95%;NS 2212;usafb-12;NSC 2212;NSC-2212;H-DL-Hcys-OH;DL-HoMocystein;DL-HOMOCYSTEINE;TOTALHOMOCYSTEINE;(+-)-homocysteine
- CBNumber:
- CB2149336
- Molecular Formula:
- C4H9NO2S
- Molecular Weight:
- 135.18
- MOL File:
- 454-29-5.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/8/13 12:20:35
| Melting point | 232-233 °C(lit.) |
|---|---|
| Boiling point | 299.7±35.0 °C(Predicted) |
| Density | 1.149 (estimate) |
| refractive index | 1.5480 (estimate) |
| Flash point | >230 °F |
| storage temp. | -20°C |
| solubility | H2O: soluble |
| pka | 2.22, 8.87, 10.86(at 25℃) |
| form | solid |
| color | White to Off-White |
| optical activity | [α]/D 0±1°, c = 1 in H2O |
| Merck | 14,4734 |
| BRN | 1721683 |
| Stability | Stable. Combustible. Incompatible with strong oxidizing agents. |
| InChIKey | FFFHZYDWPBMWHY-UHFFFAOYSA-N |
| LogP | 0.220 (est) |
| CAS DataBase Reference | 454-29-5(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |    GHS07,GHS08,GHS09 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H315-H319-H413-H372 | |||||||||
| Precautionary statements | P501-P273-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 | |||||||||
| Safety Statements | 22-24/25 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | MT0175000 | |||||||||
| F | 10-23 | |||||||||
| HS Code | 29309090 | |||||||||
| Toxicity | LD50 intraperitoneal in mouse: 500mg/kg | |||||||||
| NFPA 704 |
|
DL-Homocysteine price More Price(7)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich(India) | H4628 | DL-Homocysteine ≥95% (titration) | 454-29-5 | 10MG | ₹2500.58 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | H4628 | DL-Homocysteine ≥95% (titration) | 454-29-5 | 1G | ₹6397.58 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | H4628 | DL-Homocysteine ≥95% (titration) | 454-29-5 | 5G | ₹21476.8 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | H4628 | DL-Homocysteine ≥95% (titration) | 454-29-5 | 25G | ₹66129.93 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | 44925 | DL-Homocysteine analytical standard | 454-29-5 | 25MG | ₹7101.2 | 2022-06-14 | Buy |
DL-Homocysteine Chemical Properties,Uses,Production
Chemical Properties
white powder
Uses
DL-Homocysteine has been used to induce hyperhomocysteinemia in Sprague–Dawley rats. It has also been used to study the effects of hyperhomocysteinemia on atherosclerosis in apolipoprotein E-deficient mice.
Definition
ChEBI: A sulfur-containing amino acid consisting of a glycine core with a 2-mercaptoethyl side-chain.
Purification Methods
Purify it as for the L-isomer. [Allen & Steinmann J Am Chem Soc 74 3932 1952, and references for the L-isomer above, Beilstein 4 IV 3189.]
DL-Homocysteine Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 266)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Clearsynth Labs | 91-22-45045900 | Maharashtra, India | 3889 | 58 | Inquiry |
| Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
| A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
| CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
| TCI Chemicals (India) Pvt. Ltd. | 1800 425 7889 | New Delhi, India | 6778 | 58 | Inquiry |
| Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
| HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD | +86-15350851019 +86-15383190639 | China | 1000 | 58 | Inquiry |
| Capot Chemical Co.,Ltd. | 571-85586718 +8613336195806 | China | 29798 | 60 | Inquiry |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | China | 21661 | 55 | Inquiry |
| career henan chemical co | +86-0371-86658258 +8613203830695 | China | 29899 | 58 | Inquiry |
454-29-5(DL-Homocysteine)Related Search:
chevron_left
1of4
chevron_right
HOMOCYSTEINE, DL-(P)
DL-Homocysteine,2-Amino-4-mercaptobutyric acid
DL-HoMocystein
(+-)-homocysteine
dl-2-amino-4-mercaptobutyricacid
usafb-12
2-AMINO-4-MERCAPTOBUTYRIC ACID
2-AMINO-4-MERCAPTOBUYRIC ACID
2-amino-4-sulfanylbutanoic acid
HOMOCYSTEINE, DL-(RG)
TOTALHOMOCYSTEINE
H-DL-Hcys-OH
DL-HOMOCYSTEINE
HOMOCYSTEINE, DL-
DL-Homocysteine 2-Amino-4-mercaptobuyric acid
DL-Homocysteine 503-33-6/454-29-5
DL-Homocysteine>
DL-Homocysteine USP/EP/BP
Aminocaproic Acid Impurity 14
DL-Homocysteine 454-29-5
NS 2212
NSC 2212
NSC-2212
Butyric acid, 2-amino-4-mercapto-, DL- (9CI)
(2R)-2-ammonio-4-mercaptobutanoate
DL-Homocysteine,95%
454-29-5
503-33-6
HSC2H4CHNH2COOH
HSCH2CH2CHNH2COOH
Increased plasma homocysteine is a risk factor for coronary heart disease and carcinogenesis; may be a marker for tumor cell growth.
AMINE
Cancer Research
BioChemical
Homo-Amino Acids
Specialty Synthesis
Unnatural Amino Acid Derivatives
Tumor Promotors
Tumor Growth Regulation
Peptide Synthesis
Amino Acids
Amino Acids